I saw this post this afternoon on the PharmaGossip blog reporting on a story in The Boston Globe. It seems the rumored takeover of Genzyme by Sanofi-Aventis is making many of the Genzyme patients with Pompe's, Gaucher's and Fabry's disease nervous.
The article goes on to interview patients who explain how Genzyme has cultivated a personal relationship with them and their families over the past 15 years and how they are fearful that Sanofi would NOT be able to sustain this in an acquisition.
http://pharmagossip.blogspot.com/2010/08/genzyme-talks-trigger-patient-jitters.html.
The article does bring to light the human side of a merger from the patient's point of view -- something not generally talked about in the financial press certainly. It also shows another side to Genzyme CEO Henri Termeer - detailing his personal contact/relationship with some patients. This might be seen in marked contrast again to notes about Termeer in the business press this past year - plus even in this blog from time to time.
This is a good article to read for another perspective.
Posted by Bruce Lehr August 8th 2010.
Comments